tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LYRA Stock Latest News

Lyra Therapeutics Secures $4.3M in Direct Offering
Company AnnouncementsLyra Therapeutics Secures $4.3M in Direct Offering
20d ago
8K
LYRA
Lyra Therapeutics Regains Nasdaq Compliance in June 2025
PremiumCompany Announcements
Lyra Therapeutics Regains Nasdaq Compliance in June 2025
24d ago
8K
LYRA
Lyra Therapeutics target adjusted to $16 from $2 at H.C. Wainwright
PremiumThe Fly
Lyra Therapeutics target adjusted to $16 from $2 at H.C. Wainwright
1M ago
LYRA
Lyra Therapeutics Unveils Strategic Plans for LYR-210
PremiumCompany Announcements
Lyra Therapeutics Unveils Strategic Plans for LYR-210
1M ago
8K
LYRA
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories
PremiumMarket News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories
1M ago
DG
CLF
Lyra Therapeutics Stock (LYRA) Rockets 530% on Phase 3 Trial Results
PremiumMarket NewsLyra Therapeutics Stock (LYRA) Rockets 530% on Phase 3 Trial Results
1M ago
LYRA
Lyra Therapeutics Announces Positive Phase 3 Trial Results
Premium
Company Announcements
Lyra Therapeutics Announces Positive Phase 3 Trial Results
2M ago
8K
LYRA
Lyra Therapeutics says ENLIGHTEN 2 trial of LYR-210 met primary endpoint
Premium
The Fly
Lyra Therapeutics says ENLIGHTEN 2 trial of LYR-210 met primary endpoint
2M ago
LYRA
Lyra Therapeutics trading halted, news pending
PremiumThe Fly
Lyra Therapeutics trading halted, news pending
2M ago
LYRA
Upcoming Stock Splits This Week (May 27 to May 30) – Stay Invested
PremiumMarket News
Upcoming Stock Splits This Week (May 27 to May 30) – Stay Invested
2M ago
APVO
ASPS
Lyra Therapeutics Announces Reverse Stock Split Decision
PremiumCompany Announcements
Lyra Therapeutics Announces Reverse Stock Split Decision
2M ago
8K
LYRA
Lyra Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Lyra Therapeutics Reports Q1 2025 Financial Results
2M ago
LYRA
Lyra Therapeutics to present results from ENLIGHTEN 1 Phase 3 study
PremiumThe FlyLyra Therapeutics to present results from ENLIGHTEN 1 Phase 3 study
2M ago
LYRA
Lyra Therapeutics Reports 2024 Financial Results and Updates
Premium
Company Announcements
Lyra Therapeutics Reports 2024 Financial Results and Updates
4M ago
LYRA
Lyra Therapeutics reports Q4 EPS ($1.43), consensus (13c)
Premium
The Fly
Lyra Therapeutics reports Q4 EPS ($1.43), consensus (13c)
4M ago
LYRA
LYRA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
LYRA Earnings this Week: How Will it Perform?
5M ago
LYRA
Lyra Therapeutics Pursues ENLIGHTEN 2 Trial for LYR-210
PremiumCompany Announcements
Lyra Therapeutics Pursues ENLIGHTEN 2 Trial for LYR-210
6M ago
8K
LYRA
Lyra Therapeutics Restructures Board of Directors
PremiumCompany Announcements
Lyra Therapeutics Restructures Board of Directors
7M ago
8K
LYRA
Lyra Therapeutics reports Q3 EPS (18c), consensus (23c)
PremiumThe Fly
Lyra Therapeutics reports Q3 EPS (18c), consensus (23c)
8M ago
LYRA
LYRA Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsLYRA Upcoming Earnings Report: What to Expect?
9M ago
LYRA
Lyra Therapeutics fully enrolls Phase 3 ENLIGHTEN 2 trial of LYR-210
Premium
The Fly
Lyra Therapeutics fully enrolls Phase 3 ENLIGHTEN 2 trial of LYR-210
9M ago
LYRA
Lyra Therapeutics reports Q2 EPS (74c), consensus (33c)
Premium
The Fly
Lyra Therapeutics reports Q2 EPS (74c), consensus (33c)
11M ago
LYRA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >